The Efficacy of Chewing Gums Versus Laxative in Early Return of Bowel Function After CS
NCT ID: NCT02765971
Last Updated: 2019-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
540 participants
INTERVENTIONAL
2016-05-31
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.
* Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.
* Group C, 180 women as control group, they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chewing Gums to Stimulate Intestinal Motility After Cesarean Section
NCT02386748
the Role of Gum Chewing in Regaining Bowel Motility in Patients Undergoing Cesarean Section
NCT03547284
Prevention of Ileus After Gynecologic Surgery Using Chewing Gum
NCT00831246
Efficacy of Ginger in the Prevention of Abdominal Distention in Post Cesarean Section Patient
NCT02809027
Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological Malignancies
NCT01835119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.
* Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.
Group C, 180 women as control group, they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chewing gum group
180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval
gums
Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.
laxatives group
180 women will receive laxatives after their operating room discharge by 3 hours
picolax drops
Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.
control
they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds
normal saline
Group C received 500 cc of normal saline, Intravenous fluid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
gums
Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.
picolax drops
Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.
normal saline
Group C received 500 cc of normal saline, Intravenous fluid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* surgical management of severe postpartum hemorrhage
* previous bowel surgery
* women with history of drug consumption,especially opioids
* water and electrolyte disturbances
* pancreatitis or peritonitis
* inability to chew gum
* diabetes, pregnancies accompanied by coagulopathy like pre-eclampsia, hypothyroidism, muscular and neurological disorders
* postoperative admission to intensive care unit
* history of abdominal surgery except cesarean section
* history of postoperative ileus
* patients with drains
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahmed M Maged, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed M Maged, MD
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Maged
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr Alainy medical school
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
143
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.